Zhejiang Zhenyuan Co., Ltd. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Zhenyuan Co., Ltd. with three other
companies in this sector in China:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 1.38 billion Chinese Renmimbi [US$199.81 million]
of which 62%
was Pharmaceutical Business Trade),
China Pioneer Pharma Holdings Ltd
(1.46 billion Chinese Renmimbi [US$211.45 million]
of which 59%
was Products sold via the provision of co-pr), and
Jiangsu Nhwa Pharmaceutical Company Limited
(2.77 billion Chinese Renmimbi [US$400.28 million]
of which 51%
was Medical Industrial Manufacturing).
Zhejiang Zhenyuan Co., Ltd. reported sales of 2.16 billion Chinese Renmimbi (US$313.00 million)
December of 2015.
increase of 4.1%
versus 2014, when the company's sales were 2.08 billion Chinese Renmimbi.
Sales at Zhejiang Zhenyuan Co., Ltd. have increased during each of the previous five years
(and since 2010, sales have increased a total of 44%).
Sales of Medicines Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
8.7% in 2015, from
317.80 million Chinese Renmimbi to 345.49 million Chinese Renmimbi.
Not all segments of Zhejiang Zhenyuan Co., Ltd. experienced an increase in sales in 2015:
sales of Medicine Wholesales fell 3.3% to 1.69 billion Chinese Renmimbi.